| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 10/20/2015 | 7:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Preliminary Revenue for Third Quarter 2015 | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/29/2015 | 8:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/17/2015 | 7:02AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/10/2015 | 7:30AM | PR Newswire (US) | Imprimis Pharmaceuticals to Present at 6th Annual Craig-Hallum Alpha Select Conference | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/03/2015 | 5:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/03/2015 | 5:17PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/02/2015 | 7:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Appoints Anthony J. Principi to its Board of Directors | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/02/2015 | 7:26AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/12/2015 | 4:09PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/12/2015 | 4:05PM | PR Newswire (US) | Imprimis Pharmaceuticals Announces Second Quarter 2015 Financial Results and Provides Business Update | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/12/2015 | 4:04PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/12/2015 | 7:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Signs License Agreement to Bring Proprietary Compounded Ophthalmic Formulations to Ophthalmologists ... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/06/2015 | 7:31AM | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/05/2015 | 7:41AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/05/2015 | 7:36AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/05/2015 | 7:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Expands Distribution of its Proprietary Ophthalmic and Urologic Formulations into Texas and Virginia | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/03/2015 | 7:30AM | PR Newswire (US) | Imprimis Pharmaceuticals to Host its Second Quarter 2015 Financial Report, Conference Call and Webcast on August 12, 2015 at ... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/16/2015 | 4:01PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/01/2015 | 9:00AM | PR Newswire (US) | Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/30/2015 | 3:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/23/2015 | 7:30AM | PR Newswire (US) | Imprimis Pharmaceuticals Acquires Proprietary Compounded Conscious Sedation Formulations | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/20/2015 | 4:20PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/20/2015 | 4:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/20/2015 | 12:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/20/2015 | 11:58AM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/20/2015 | 11:13AM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/20/2015 | 11:10AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/19/2015 | 8:29AM | InvestorsHub NewsWire | EDISON EQUITY RESEARCH - IMPRIMIS PHARMACEUTICALS | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/18/2015 | 7:30AM | PR Newswire (US) | Canadian Journal of Urology Study Highlights the Benefits of Heparin and Alkalinized Lidocaine Combination Formulation for th... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |